ConductScience.org, home

Comparison · NCT03348683-56bf3b20

Propranolol vs Placebo: Number of Participants With Postpartum Hemorrhage

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Propranolol vs Placebo: Number of Participants With Postpartum Hemorrhage. Trial comparisons, record NCT03348683-56bf3b20. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03348683-56bf3b20

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.1240.07660.194wilson
Risk in group 20.2180.1540.301wilson
Risk difference, group 1 minus group 2-0.0945-0.190.00125newcombe hybrid score
Risk ratio, group 1 over group 20.5670.3171.02log
Odds ratio, group 1 over group 20.5060.2531.01log
Number needed to treat, for one fewer participant with the outcome on Propranolol than on Placebo10.6from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: placebo.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1PropranololAfter induction was started with Foley or misoprostol placement, 30 minutes passed before administration of propranolol 2mg of IV push15121OG000
Group 2PlaceboAfter induction was started with Foley or misoprostol placement, 30 minutes passed before administration of an equivalent quantity in milliliters of IV normal saline26119OG001

Outcome

Type
SECONDARY
Title
Number of Participants With Postpartum Hemorrhage
Description
Greater than 500cc of blood expelled during a vaginal delivery or greater than 1000cc of blood expelled during a cesarean section
Time frame
30 minutes from drug administration
Population

Source ClinicalTrials.gov

Trial

Title
Propranolol Versus Placebo for Induction of Labor in Nulliparous Patients
NCT number
NCT03348683
Phases
PHASE2
Conditions
Induction of Labor Affected Fetus / Newborn
Interventions
Propranolol, Placebo
Lead sponsor
Icahn School of Medicine at Mount Sinai
Results first posted
2019-12-26

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT03348683-56bf3b20